90 DAYS: An Entertainment Education Intervention to Evaluate a Short Film About HIV Status Disclosure
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03898063|
Recruitment Status : Completed
First Posted : April 1, 2019
Results First Posted : July 2, 2021
Last Update Posted : July 2, 2021
|Condition or disease||Intervention/treatment||Phase|
|HIV/AIDS||Behavioral: 90 DAYS film Behavioral: HIV pamphlet on disclosure||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||148 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Primary Purpose:||Supportive Care|
|Official Title:||An Experimental Investigation of the Effects of an Entertainment Education Short Film on Internalized HIV-related Stigma, Sexual Partner Status Disclosure, and Medical Adherence Intentions Among Black HIV-positive Women in Miami-Dade County|
|Actual Study Start Date :||June 17, 2019|
|Actual Primary Completion Date :||May 31, 2020|
|Actual Study Completion Date :||May 31, 2020|
Active Comparator: Control
participants will receive a standard-of-care brochure detailing HIV status disclosure.
Behavioral: HIV pamphlet on disclosure
A standard-of-care brochure given to newly diagnosed HIV patients about the importance of status disclosure
Experimental: intervention: 90 DAYS film
participants will watch the film, 90 DAYS
Behavioral: 90 DAYS film
the intervention conditions include exposure to a film, 90 DAYS (approx 20 minutes long), an entertainment film detailing a woman's decision to tell her romantic partner that she is HIV-positive.
- HIV Self-stigmatization as Assessed Via Self Stigmatization Questionnaire [ Time Frame: Day 1 post test ]self-report measure of the extent to which participants stigmatize themselves for being HIV positive. Quantified in the manuscript using the mean of the self-report scale. Scores range from 1-5 with higher scores indicating higher perceptions of self-stigmatization.
- HIV Disclosure Intentions as Assessed by Disclosure Intentions Scale [ Time Frame: Day 1 post-test ]Self-report measure of the extent to which participants intend to disclose their HIV status to a partner. Quantified in the manuscript using the mean of the self-report scale. Scores range from 1-5 with higher scores indicating higher intentions of status disclosure.
- Medical Adherence Intentions as Measured by the Medical Adherence Scale [ Time Frame: Day 1 post-test ]Self-report measure of participants likeliness to miss doses of their antiretroviral medication over a 30 day period. Quantified in the manuscript using the mean of the self-report scale. Scores range from 1-5 with higher scores indicating increased likeliness to miss doses of antiretroviral medication.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03898063
|United States, Florida|
|University of Miami Medical Campus|
|Miami, Florida, United States, 33136|
|Principal Investigator:||Nicholas Carcioppolo, PhD||University of Miami|